Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prostaglandin E agonists for treatment of glaucoma

Prostaglandin E agonists for treatment of glaucoma

US Patent 6545045 · Granted Apr 8, 2003

Estimated economic value: $139,397,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compoun2022
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2018
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2017
Topical ocular analgesic agents2015
Use of bradykinin and related B2R agonists to treat ocular hypertension and glau2012
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and g2012
Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension an2012
Superoxide dismutase mimics for the treatment of ocular disorders and diseases2011
Methods for identifying peptides that bind to intact oocytes2011
Method of treating ocular allergy2011
Superoxide dismutase mimics for the treatment of ocular disorders and diseases2011
Method of treating dry eye disorders and uveitis2011